Skip to main content
logo
Mezzion Pharma Co.,Ltd. (KOSDAQ:140410)
South Korea flag South Korea · Delayed Price · Currency is KRW
63,800
-500 (-0.78%)
Aug 20, 2026, 3:30 PM KST

Mezzion Pharma Balance Sheet

Millions KRW. Fiscal year is Jan - Dec.

Assets

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
17,41925,57413,61740,24629,39924,210
Short-Term Investments
--15,00018,0003,00023,284
Cash & Short-Term Investments
17,41925,57428,61758,24632,39947,494
Cash Growth
-17.37%-10.63%-50.87%79.78%-31.78%-3.28%
Accounts Receivable
939.071,078869.932,3092,6442,368
Other Receivables
597.07202.26457.472,154238.76377.57
Receivables
2,2561,9901,7575,9254,2034,435
Inventory
5,2425,3025,4205,7428,83511,777
Prepaid Expenses
227.35113.77127.5136.44265.05266.77
Other Current Assets
13,16912,6066,0044,194195.28201.3
Total Current Assets
38,31345,58641,92674,24445,89764,174
Property, Plant & Equipment
2,3822,5162,5292,8544,2454,879
Long-Term Investments
003.087.46--0
Other Intangible Assets
1,6201,6201,6201,6201,6201,620
Long-Term Deferred Charges
55,86447,49826,82011,324-12,559
Other Long-Term Assets
643.02694.49821.11,9511,950672.93
Total Assets
98,92298,02573,99892,14954,02283,935

Liabilities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Accounts Payable
1,8191,8101,6464,0307,1735,503
Accrued Expenses
25,21323,69218,88221,831-7,188
Short-Term Debt
10,5569,910-499.581,063932.01
Current Portion of Leases
831.99812.5694.38735.87-1,051
Current Income Taxes Payable
--3,892---
Other Current Liabilities
43,84643,3491,5562,51917,8443,823
Total Current Liabilities
82,26779,57226,67029,61526,08018,497
Long-Term Leases
1,0321,151921.471,005-2,338
Pension & Post-Retirement Benefits
5.15----217.2
Long-Term Deferred Tax Liabilities
--251.42---
Other Long-Term Liabilities
106.98106.6291.9884.611,70289.78
Total Liabilities
83,41180,83027,93530,70527,78221,141

Shareholders' Equity

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Common Stock
15,19615,18214,98214,80413,3714,451
Additional Paid-In Capital
174,622173,602159,062150,51099,256107,802
Retained Earnings
-183,459-178,129-143,148-123,723-111,052-74,789
Comprehensive Income & Other
9,1516,53915,16719,85424,66525,330
Shareholders' Equity
15,51117,19546,06361,44426,24062,793
Total Liabilities & Equity
98,92298,02573,99892,14954,02283,935

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Total Debt
12,42111,8731,6162,2411,0634,321
Net Cash (Debt)
4,99813,70127,00156,00631,33643,173
Net Cash Growth
-74.50%-49.26%-51.79%78.73%-27.42%-1.88%
Net Cash Per Share
165.52454.88905.271983.281172.201617.75
Filing Date Shares Outstanding
30.3930.3629.9629.6126.7426.7
Total Common Shares Outstanding
30.3930.3629.9629.6126.7426.7
Working Capital
-43,953-33,98715,25544,62819,81745,678
Book Value Per Share
510.36566.281537.302075.31981.232351.55
Tangible Book Value
13,89115,57544,44359,82524,62061,174
Tangible Book Value Per Share
457.07512.941483.242020.60920.662290.89
Buildings
----23.9723.97
Machinery
-2,1832,1911,9763,5232,908
Construction In Progress
---619.69439.17193.43